The Department of Radiation Oncology at the UF Health Shands Hospital provides a full range of radiation treatment services for almost all kinds of tumors at almost all body sites. We employ state-of-the-art technologies in order to achieve best possible treatment outcomes. Our radiation oncologists, medical physicists, and dosimetrists work closely to design treatment plans that optimally deliver radiation to the target volumes while minimizing radiation dose to surrounding normal tissues.
Modern treatment techniques, such as intensity-modulated radiation therapy (IMRT) and volumetric-modulated radiation therapy (VMAT), are employed using our medical linear accelerators (LINAC) for the majority of patients. In addition, our department offers specialized treatments such as total body irradiation (TBI), total skin electron therapy (TSET), stereotactic radiosurgery (SRS), and stereotactic body radiation therapy (SBRT). The department also has a high dose-rate (HDR) brachytherapy unit for gynecological (GYN) applications and an intra-operative IntraBeam unit for breast treatment. The department is constantly evaluating new technologies in order to bring the best options to our patients.
The first step in designing a radiation therapy treatment plan is treatment simulation through a CT and/or MR scan.
We use the Pinnacle 3-dimensional (3D) treatment planning system in most cases for accurate dose calculation.
We use a variety of treatment techniques and medical linear accelerators to treat malignant tumors or benign lesions.
A typical course of radiation therapy lasts 5-7 weeks with daily treatment – accurate tumor targeting depends on proper patient positioning.
Both SRS and SBRT treatments are special techniques that rely on precise localization of target volumes based on 3D imaging.
MR-guided radiation therapy (MRgRT) has increasingly been recognized as an important element in successfully treating many types of cancer.
In contrast to external beam radiation therapy, brachytherapy uses a radioactive source which is placed in close proximity to, or directly in, the tumor using a needle or catheter.
How we employ oral and injected radiopharmaceuticals to treat thyroid, prostate, and neuroendocrine cancers.